SERPINA3 monoclonal antibody (M04), clone 3F5
* The price is valid only in USA. Please select country.
Sandwich ELISA (Recombinant protein)
Detection limit for recombinant GST tagged SERPINA3 is 0.3 ng/ml as a capture antibody.
Mouse monoclonal antibody raised against a full-length recombinant SERPINA3.
SERPINA3 (AAH10530, 1 a.a. ~ 423 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Interspecies Antigen Sequence
Mouse (58); Rat (61)
Quality Control Testing
Antibody Reactive Against Recombinant Protein.
In 1x PBS, pH 7.4
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Sandwich ELISA (Recombinant protein)Detection limit for recombinant GST tagged SERPINA3 is 0.3 ng/ml as a capture antibody.
Gene Info — SERPINA3
AACT, ACT, GIG24, GIG25, MGC88254
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
The protein encoded by this gene is a plasma protease inhibitor and member of the serine protease inhibitor class. Polymorphisms in this protein appear to be tissue specific and influence protease targeting. Variations in this protein's sequence have been implicated in Alzheimer's disease, and deficiency of this protein has been associated with liver disease. Mutations have been identified in patients with Parkinson disease and chronic obstructive pulmonary disease. [provided by RefSeq
alpha-1-antichymotrypsin|antichymotrypsin|growth-inhibiting protein 24|growth-inhibiting protein 25|serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3|serine (or cysteine) proteinase inhibitor, clade A, memb
+ View More Disease
- View Less Disease
Proteomic analysis of human Epithelial Lining Fluid by microfluidics-based nanoLC-MS/MS: a feasibility study.
Franciosi L, Govorukhina N, Fusetti F, Poolman B, Lodewijk ME, Timens W, Postma D, ten Hacken N, Bischoff R.
Electrophoresis 2013 Sep; 34(18):2683.
Application：IHC, Human, Lung.
- Proteomic analysis of human Epithelial Lining Fluid by microfluidics-based nanoLC-MS/MS: a feasibility study.